Outset Medical — Third Quarter 2026 Earnings Summary

Outset Medical reported third-quarter 2026 net revenue of $33.6 million, representing a 14% increase year-over-year and a 6% sequential increase. Gross margin expanded to 40.7%, driven by a 26% rise in console revenue and a 10% increase in recurring revenue from Tablo consumables and services. The company recorded a net loss of $14.7 million for the quarter, while maintaining a cash position of $140.7 million at the end of the period. Outset reiterated its full-year 2026 revenue guidance of $125 million to $130 million and expects non-GAAP gross margins to remain in the low-40% to mid-40% range.